The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Tumor-Infiltrating Natural Killer Cells
Open accessAbstract
Because of their potent antitumor activity and their proinflammatory role, natural killer (NK) cells are at the forefront of efforts to develop immuno-oncologic treatments. NK cells participate in immune responses to tumors by killing target cells and producing cytokines. However, in the immunosuppressive tumor microenvironment, NK cells become dysfunctional through exposure to inhibitory molecules produced by cancer cells, leading to tumor escape. We provide an overview of what is known about NK tumor infiltration and surveillance and about the mechanisms by which NK cells become dysfunctional.Significance: The functions of tumor-infiltrating NK cells may be impaired. This review aims to describe the various mechanisms by which tumors alter NK-cell functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
NK cell heparanase controls tumor invasion and immune surveillance
Putz, E. M., Mayfosh, A. J., Kos, K., Barkauskas, D. S., Nakamura, K., Town, L., Goodall, K. J., Yee, D. Y., Poon, I. K. H., Baschuk, N., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92958 · Cited by 105
RetractedRobust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
Innate lymphoid cells — a proposal for uniform nomenclature
Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N. J., Mebius, R. E., et al. (2013) · Nature Reviews Immunology · doi:10.1038/nri3365 · Cited by 2,389
Self-citationKiessling, R., Klein, E., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050208 · Cited by 1,824
André, P., Denis, C., Soulas, C., Bourbon-Caillet, C., Lopez, J., Arnoux, T., Bléry, M., Bonnafous, C., Gauthier, L., Morel, A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.014 · Cited by 1,221
Self-citationZhang, Q., Bi, J., Zheng, X., Chen, Y., Wang, H., Wu, W., Wang, Z., Wu, Q., Peng, H., Wei, H., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0132-0 · Cited by 1,122
A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
Barry, K. C., Hsu, J., Broz, M. L., Cueto, F. J., Binnewies, M., Combes, A. J., Nelson, A. E., Loo, K., Kumar, R., Rosenblum, M. D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0085-8 · Cited by 1,021
Natural killer cells and other innate lymphoid cells in cancer
Chiossone, L., Dumas, P.-Y., Vienne, M., & Vivier, E. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0061-z · Cited by 1,007
Self-citationGhiringhelli, F., Ménard, C., Terme, M., Flament, C., Taieb, J., Chaput, N., Puig, P. E., Novault, S., Escudier, B., Vivier, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051511 · Cited by 949
Self-citationImmunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
Lanier, L. L., Corliss, B. C., Wu, J., Leong, C., & Phillips, J. H. (1998) · Nature · doi:10.1038/35642 · Cited by 904
The Broad Spectrum of Human Natural Killer Cell Diversity
Freud, A. G., Mundy-Bosse, B. L., Yu, J., & Caligiuri, M. A. (2017) · Immunity · doi:10.1016/j.immuni.2017.10.008 · Cited by 695
Mamessier, E., Sylvain, A., Thibult, M.-L., Houvenaeghel, G., Jacquemier, J., Castellano, R., Gonçalves, A., André, P., Romagné, F., Thibault, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45816 · Cited by 681
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Gao, Y., Souza-Fonseca-Guimaraes, F., Bald, T., Ng, S. S., Young, A., Ngiow, S. F., Rautela, J., Straube, J., Waddell, N., Blake, S. J., et al. (2017) · Nature Immunology · doi:10.1038/ni.3800 · Cited by 654
Self-citationLee, J.-C., Lee, K.-M., Kim, D.-W., & Heo, D. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7335 · Cited by 549
Campbell, J. J., Qin, S., Unutmaz, D., Soler, D., Murphy, K. E., Hodge, M. R., Wu, L., & Butcher, E. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6477 · Cited by 517
NK Cell Metabolism and Tumor Microenvironment
Terrén, I., Orrantia, A., Vitallé, J., Zenarruzabeitia, O., & Borrego, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02278 · Cited by 501
Romagnani, C., Juelke, K., Falco, M., Morandi, B., D’Agostino, A., Costa, R., Ratto, G., Forte, G., Carrega, P., Lui, G., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.4947 · Cited by 494
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46
Walzer, T., Bléry, M., Chaix, J., Fuseri, N., Chasson, L., Robbins, S. H., Jaeger, S., André, P., Gauthier, L., Daniel, L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609692104 · Cited by 476
Self-citationCD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells
Jacobs, R., Hintzen, G., Kemper, A., Beul, K., Kempf, S., Behrens, G., Sykora, K.-W., & Schmidt, R. E. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<3121::aid-immu3121>3.0.co;2-4 · Cited by 475
Crinier, A., Milpied, P., Escalière, B., Piperoglou, C., Galluso, J., Balsamo, A., Spinelli, L., Cervera-Marzal, I., Ebbo, M., Girard-Madoux, M., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.009 · Cited by 470
Self-citationPesce, S., Greppi, M., Tabellini, G., Rampinelli, F., Parolini, S., Olive, D., Moretta, L., Moretta, A., & Marcenaro, E. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.04.025 · Cited by 465
Self-citationAntibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
Ferrari de Andrade, L., Tay, R. E., Pan, D., Luoma, A. M., Ito, Y., Badrinath, S., Tsoucas, D., Franz, B., May, K. F., Harvey, C. J., et al. (2018) · Science · doi:10.1126/science.aao0505 · Cited by 459
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
Gauthier, L., Morel, A., Anceriz, N., Rossi, B., Blanchard-Alvarez, A., Grondin, G., Trichard, S., Cesari, C., Sapet, M., Bosco, F., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.041 · Cited by 439
Self-citationAbsence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Paczulla, A. M., Rothfelder, K., Raffel, S., Konantz, M., Steinbacher, J., Wang, H., Tandler, C., Mbarga, M., Schaefer, T., Falcone, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1410-1 · Cited by 391
Pende, D., Falco, M., Vitale, M., Cantoni, C., Vitale, C., Munari, E., Bertaina, A., Moretta, F., Del Zotto, G., Pietra, G., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01179 · Cited by 389
Fauriat, C., Just-Landi, S., Mallet, F., Arnoulet, C., Sainty, D., Olive, D., & Costello, R. T. (2007) · Blood · doi:10.1182/blood-2005-08-027979 · Cited by 380
Liu, Y., Cheng, Y., Xu, Y., Wang, Z., Du, X., Li, C., Peng, J., Gao, L., Liang, X., & Ma, C. (2017) · Oncogene · doi:10.1038/onc.2017.209 · Cited by 366
Immune Cell Composition in Human Non-small Cell Lung Cancer
Stankovic, B., Bjørhovde, H. A. K., Skarshaug, R., Aamodt, H., Frafjord, A., Müller, E., Hammarström, C., Beraki, K., Bækkevold, E. S., Woldbæk, P. R., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03101 · Cited by 341
Cortez, V. S., Ulland, T. K., Cervantes-Barragan, L., Bando, J. K., Robinette, M. L., Wang, Q., White, A. J., Gilfillan, S., Cella, M., & Colonna, M. (2017) · Nature Immunology · doi:10.1038/ni.3809 · Cited by 332
Majoros, A., Platanitis, E., Kernbauer-Hölzl, E., Rosebrock, F., Müller, M., & Decker, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00029 · Cited by 325
Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance
Zheng, X., Qian, Y., Fu, B., Jiao, D., Jiang, Y., Chen, P., Shen, Y., Zhang, H., Sun, R., Tian, Z., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0511-1 · Cited by 316
Natural killer cell-mediated immunosurveillance of human cancer
Malmberg, K.-J., Carlsten, M., Björklund, A., Sohlberg, E., Bryceson, Y. T., & Ljunggren, H.-G. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.002 · Cited by 299
Cursons, J., Souza-Fonseca-Guimaraes, F., Foroutan, M., Anderson, A., Hollande, F., Hediyeh-Zadeh, S., Behren, A., Huntington, N. D., & Davis, M. J. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0500 · Cited by 296
Sun, C., Xu, J., Huang, Q., Huang, M., Wen, H., Zhang, C., Wang, J., Song, J., Zheng, M., Sun, H., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1264562 · Cited by 288
Carlsten, M., Norell, H., Bryceson, Y. T., Poschke, I., Schedvins, K., Ljunggren, H.-G., Kiessling, R., & Malmberg, K.-J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901226 · Cited by 283
Olcese, L., Cambiaggi, A., Semenzato, G., Bottino, C., Moretta, A., & Vivier, E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5083 · Cited by 262
Self-citationA shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
Deng, W., Gowen, B. G., Zhang, L., Wang, L., Lau, S., Iannello, A., Xu, J., Rovis, T. L., Xiong, N., & Raulet, D. H. (2015) · Science · doi:10.1126/science.1258867 · Cited by 255
Cutting Edge: Identification and Characterization of Human Intrahepatic CD49a+ NK Cells
Marquardt, N., Béziat, V., Nyström, S., Hengst, J., Ivarsson, M. A., Kekäläinen, E., Johansson, H., Mjösberg, J., Westgren, M., Lankisch, T. O., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402756 · Cited by 254
Stiff, A., Trikha, P., Mundy-Bosse, B., McMichael, E., Mace, T. A., Benner, B., Kendra, K., Campbell, A., Gautam, S., Abood, D., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0691 · Cited by 244
Reiners, K. S., Topolar, D., Henke, A., Simhadri, V. R., Kessler, J., Sauer, M., Bessler, M., Hansen, H. P., Tawadros, S., Herling, M., et al. (2013) · Blood · doi:10.1182/blood-2013-01-476606 · Cited by 239
Antibody-dependent Cell-mediated Cytotoxicity due to a “Null” Lymphoid Cell
GREENBERG, A. H., HUDSON, L., SHEN, L., & ROITT, I. M. (1973) · Nature New Biology · doi:10.1038/newbio242111a0 · Cited by 234
Stringaris, K., Sekine, T., Khoder, A., Alsuliman, A., Razzaghi, B., Sargeant, R., Pavlu, J., Brisley, G., de Lavallade, H., Sarvaria, A., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.087536 · Cited by 231
Glasner, A., Levi, A., Enk, J., Isaacson, B., Viukov, S., Orlanski, S., Scope, A., Neuman, T., Enk, C. D., Hanna, J. H., et al. (2018) · Immunity · doi:10.1016/j.immuni.2017.12.007 · Cited by 222
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function
Montaldo, E., Zotto, G. D., Chiesa, M. D., Mingari, M. C., Moretta, A., Maria, A. D., & Moretta, L. (2013) · Cytometry Part A · doi:10.1002/cyto.a.22302 · Cited by 218
Schlecker, E., Fiegler, N., Arnold, A., Altevogt, P., Rose-John, S., Moldenhauer, G., Sucker, A., Paschen, A., von Strandmann, E. P., Textor, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3017 · Cited by 216
Petricevic, B., Laengle, J., Singer, J., Sachet, M., Fazekas, J., Steger, G., Bartsch, R., Jensen-Jarolim, E., & Bergmann, M. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-307 · Cited by 192
Paschen, A., Sucker, A., Hill, B., Moll, I., Zapatka, M., Nguyen, X. D., Sim, G. C., Gutmann, I., Hassel, J., Becker, J. C., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0886 · Cited by 192
Evidence for NK Cell Subsets Based on Chemokine Receptor Expression
Berahovich, R. D., Lai, N. L., Wei, Z., Lanier, L. L., & Schall, T. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7833 · Cited by 191
Wu, J., Gao, F.-X., Wang, C., Qin, M., Han, F., Xu, T., Hu, Z., Long, Y., He, X.-M., Deng, X., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1310-0 · Cited by 187
Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways
Coudert, J. D., Scarpellino, L., Gros, F., Vivier, E., & Held, W. (2008) · Blood · doi:10.1182/blood-2007-07-100057 · Cited by 185
Self-citationMigration and Tissue Tropism of Innate Lymphoid Cells
Kim, C. H., Hashimoto-Hill, S., & Kim, M. (2016) · Trends in Immunology · doi:10.1016/j.it.2015.11.003 · Cited by 180
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape
Pesce, S., Tabellini, G., Cantoni, C., Patrizi, O., Coltrini, D., Rampinelli, F., Matta, J., Vivier, E., Moretta, A., Parolini, S., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.1001224 · Cited by 178
Self-citationDodagatta-Marri, E., Meyer, D. S., Reeves, M. Q., Paniagua, R., To, M. D., Binnewies, M., Broz, M. L., Mori, H., Wu, D., Adoumie, M., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0493-9 · Cited by 177
Tumor-Associated Monocytes/Macrophages Impair NK-Cell Function via TGFβ1 in Human Gastric Cancer
Peng, L.-S., Zhang, J.-Y., Teng, Y.-S., Zhao, Y.-L., Wang, T.-T., Mao, F.-Y., Lv, Y.-P., Cheng, P., Li, W.-H., Chen, N., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0152 · Cited by 172
Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients
Semeraro, M., Rusakiewicz, S., Minard‐Colin, V., Delahaye, N. F., Enot, D. P., Vely, F., Marabelle, A., Papoular, B., Pipéroglou, C., Ponzoni, M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa2327 · Cited by 164
Park, A., Lee, Y., Kim, M. S., Kang, Y. J., Park, Y.-J., Jung, H., Kim, T.-D., Lee, H. G., Choi, I., & Yoon, S. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01859 · Cited by 163
Rouce, R. H., Shaim, H., Sekine, T., Weber, G., Ballard, B., Ku, S., Barese, C., Murali, V, Wu, M.-F., Liu, H., et al. (2016) · Leukemia · doi:10.1038/leu.2015.327 · Cited by 161
Zhang, Q.-F., Yin, W.-W., Xia, Y., Yi, Y.-Y., He, Q.-F., Wang, X., Ren, H., & Zhang, D.-Z. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.28 · Cited by 161
Seo, H., Jeon, I., Kim, B.-S., Park, M., Bae, E.-A., Song, B., Koh, C.-H., Shin, K.-S., Kim, I.-K., Choi, K., et al. (2017) · Nature Communications · doi:10.1038/ncomms15776 · Cited by 161
PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients
Concha-Benavente, F., Kansy, B., Moskovitz, J., Moy, J., Chandran, U., & Ferris, R. L. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0062 · Cited by 161
NK cells and T cells cooperate during the clinical course of colorectal cancer
Sconocchia, G., Eppenberger, S., Spagnoli, G. C., Tornillo, L., Droeser, R. A., Caratelli, S., Ferrelli, F., Coppola, A., Arriga, R., Lauro, D., et al. (2014) · OncoImmunology · doi:10.4161/21624011.2014.952197 · Cited by 156
Minimal PD-1 expression in mouse and human NK cells under diverse conditions
Judge, S. J., Dunai, C., Aguilar, E. G., Vick, S. C., Sturgill, I. R., Khuat, L. T., Stoffel, K. M., Dyke, J. V., Longo, D. L., Darrow, M. A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133353 · Cited by 149
Harel‐Bellan, A., Quillet‐Mary, A., Marchiol, C., DeMars, R., Tursz, T., & FRADELIZI, D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.15.5688 · Cited by 142
Jin, F., Zhaozhen, W., Hu, X., Zhang, J., Zihe, G., Xiao, H., Junfang, Q., Chen, L., & Wang, Y. (2019) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2018.0253 · Cited by 142
Overexpression of Necl‐5 correlates with unfavorable prognosis in patients with lung adenocarcinoma
Nakai, R., Maniwa, Y., Tanaka, Y., Nishio, W., Yoshimura, M., Okita, Y., Ohbayashi, C., Satoh, N., Ogita, H., Takai, Y., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01530.x · Cited by 134
Han, B., Mao, F.-Y., Zhao, Y., Lv, Y.-P., Teng, Y., Duan, M., Chen, W., Cheng, P., Wang, T., Liang, Z.-Y., et al. (2018) · Journal of Immunology Research · doi:10.1155/2018/6248590 · Cited by 130
Discovery of specialized NK cell populations infiltrating human melanoma metastases.
de Andrade, L. D., Lu, Y.-H., Luoma, A. M., Ito, Y., Pan, D., Pyrdol, J. W., Yoon, C., Yuan, G.-C., & Wucherpfennig, K. (2019) · JCI Insight · doi:10.1172/jci.insight.133103 · Cited by 124
Galland, S., Vuille, J. A., Martin, P., Letovanec, I., Caignard, A., Fregni, G., & Stamenkovic, I. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.089 · Cited by 116
Izawa, S., Kono, K., Mimura, K., Kawaguchi, Y., Watanabe, M., Maruyama, T., & Fujii, H. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1082-7 · Cited by 105
Sun, H., Liu, L., Huang, Q., Liu, H., Huang, M., Wang, J., Wen, H., Lin, R., Qu, K., Li, K., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0757 · Cited by 100
NK Cell Phenotypic Modulation in Lung Cancer Environment
Jin, S., Deng, Y.-N., Hao, J.-W., Li, Y., Liu, B., Yu, Y., Shi, F.-D., & Zhou, Q.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109976 · Cited by 94
Location of the Proto-Atlantic Suture in the British Isles
Gunn, P. J. (1973) · Nature · doi:10.1038/242111a0 · Cited by 92
Cluxton, C. D., Spillane, C. D., O’Toole, S. A., Sheils, O. M., Gardiner, C. M., & O’Leary, J. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211538 · Cited by 92
Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
Thompson, T. W., Kim, A. B., Li, P. J., Wang, J., Jackson, B. T., Huang, K. T. H., Zhang, L., & Raulet, D. H. (2017) · eLife · doi:10.7554/elife.30881 · Cited by 87
Human NK cell response to pathogens
Chiesa, M. D., Marcenaro, E., Sivori, S., Carlomagno, S., Pesce, S., & Moretta, A. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.02.001 · Cited by 84
Reduction of the CD16−CD56bright NK Cell Subset Precedes NK Cell Dysfunction in Prostate Cancer
Koo, K. C., Shim, D. H., Yang, C. M., Lee, S.-B., Kim, S. M., Shin, T. Y., Kim, K. H., Yoon, H., Rha, K. H., Lee, J. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078049 · Cited by 80
MHC/HLA Class I Loss in Cancer Cells
Garrido, F. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-17864-2_2 · Cited by 79
Close, H. J., Stead, L. F., Nsengimana, J., Reilly, K., Droop, A., Wurdak, H., Mathew, R. K., Corns, R. A., Newton‐Bishop, J., Melcher, A. A., et al. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13403 · Cited by 77
WANG, D., Saga, Y., Mizukami, H., Sato, N., NONAKA, H., Fujiwara, H., Takei, Y., 町田, 静., Takikawa, O., Ozawa, K., et al. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1295 · Cited by 74
Mantovani, S., Oliviero, B., Lombardi, A., Varchetta, S., Mele, D., Sangiovanni, A., Rossi, G. E., Donadon, M., Torzilli, G., Soldani, C., et al. (2018) · Hepatology · doi:10.1002/hep.30235 · Cited by 73
Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancer
Peng, Y., Xi, C., Zhu, Y., Yin, L., Wei, J., Zhang, J., Liu, X., Guo, S., Fu, Y., & Miao, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11953 · Cited by 71
Chrétien, A.-S., Devillier, R., Fauriat, C., Orlanducci, F., Harbi, S., Roy, A. L., Rey, J., Bouvier, G., Gautherot, E., Hamel, J.-F., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1307491 · Cited by 66
Vujanović, L., Chuckran, C. A., Lin, Y., Ding, F., Sander, C., Santos, P. M., Lohr, J., Mashadi-Hossein, A., Warren, S., White, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00014 · Cited by 62
Activating killer cell immunoglobulin‐like receptors: Detection, function and therapeutic use
Blunt, M. D., & Khakoo, S. I. (2019) · International Journal of Immunogenetics · doi:10.1111/iji.12461 · Cited by 62
Costello, R. T., Knoblauch, B., Sanchez, C., Mercier, D. L., Treut, T. L., & Sébahoun, G. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03521.x · Cited by 59
Veuillen, C., Aurran, T., Castellano, R., Rey, J., Mallet, F., Orlanducci, F., Pouyet, L., Just‐Landi, S., Coso, D., Ivanov, V., et al. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9624-5 · Cited by 57
van der Ploeg, K., Chang, C., Ivarsson, M. A., Moffett, A., Wills, M. R., & Trowsdale, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00298 · Cited by 56
Weil, S., Memmer, S., Lechner, A., Huppert, V., Giannattasio, A., Becker, T., Müller-Runte, A., Lampe, K., Beutner, D., Quaas, A., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00387 · Cited by 54
Li, Y., Zhou, Q., Song, Q., Wang, R., Lyu, S., Guan, X., Zhao, Y., & Wu, J.-P. (2020) · Journal of Immunology Research · doi:10.1155/2020/3948928 · Cited by 53
Klöß, S., Chambron, N., Gardlowski, T., Arseniev, L., Koch, J., Esser, R., Glienke, W., Seitz, O., & Koehl, U. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1055993 · Cited by 51
The Atypical Chemokine Receptor Ackr2 Constrains NK Cell Migratory Activity and Promotes Metastasis
Hansell, C. A. H., Fraser, A. R., Hayes, A. J., Pingen, M., Burt, C. L., Lee, K. M., Medina‐Ruiz, L., Brownlie, D., MacLeod, M. K. L., Burgoyne, P., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800131 · Cited by 45
Comprehensive Phenotyping of Human PB NK Cells by Flow Cytometry
Zotto, G. D., Antonini, F., Pesce, S., Moretta, F., Moretta, L., & Marcenaro, E. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24001 · Cited by 41
How melanoma cells inactivate NK cells
Pietra, G., Vitale, M., Moretta, L., & Mingari, M. C. (2012) · OncoImmunology · doi:10.4161/onci.20405 · Cited by 38
A comprehensive approach to gene expression profiling in immune cells
Carpentier, S., Romagné, F., & Vivier, É. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.07.005 · Cited by 2
Self-citation
Cited by
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Jhunjhunwala, S., Hammer, C., & Delamarre, L. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00339-z · Cited by 1,490
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Wolf, N. K., Kissiov, D. U., & Raulet, D. H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00732-1 · Cited by 577
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
Korman, A. J., Garrett-Thomson, S. C., & Lonberg, N. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00345-8 · Cited by 548
Neutrophil extracellular traps in homeostasis and disease
Wang, H., Kim, S. J., Lei, Y., Wang, S., Wang, H., Huang, H., Zhang, H., & Tsung, A. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01933-x · Cited by 537
Immunotherapy: Reshape the Tumor Immune Microenvironment
LV, B., Wang, Y., Ma, D., Cheng, W., Liu, J., Yong, T., Chen, H., & Wang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844142 · Cited by 482
Metadata
- Authors
- Cózar, B., Greppi, M., Carpentier, S., Narni-Mancinelli, E., Chiossone, L., & Vivier, E.
- Venue
- Cancer Discovery
- Published
- 2021-01-01
- Volume
- 11
- Issue
- 1
- Pages
- 34-44
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W3106704421
- Cited by
- 476
- References
- 95
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.